Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes.

By Praga Terente, Manuel. The lancet. Diabetes & endocrinology, 2015 . 3(5):382-91. , Formato Vancouver: Porrini E, Ruggenenti P, Mogensen CE, Barlovic DP, Praga M, Cruzado JM et al; ERA-EDTA diabesity working group. Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes. Lancet Diabetes Endocrinol. 2015 May;3(5):382-91.

Place Hold on Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes.

Does midlife obesity really lower dementia risk?.

By Pareja Galeano, Helios | Sanchis Gomar, Fabián | Morán Jiménez, María Josefa | Lucía, Alejandro. The lancet. Diabetes & endocrinology, 2015 . 3(7):499. , Formato Vancouver: Pareja Galeano H, Sanchís Gomar F, Alis R, Morán M, Lucía A. Does midlife obesity really lower dementia risk? Lancet Diabetes Endocrinol. 2015 Jul;3(7):499.

Place Hold on Does midlife obesity really lower dementia risk?.

Search for 'Provider:The lancet. Diabetes '

Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes.

Does midlife obesity really lower dementia risk?.